Ulwazi olusisiseko
| Igama lemveliso | Ikhathalogu | Uhlobo | Umamkeli/uMthombo | Ukusetyenziswa | Usetyenziso | I-Epitope | I-COA |
| I-Blocker Antibody | BMGBL01 | I-Monoclonal | Impuku | Isampulu yoNyango lwePad | LF, IFA, IB, WB | / | Khuphela |
| I-Blocker Antibody | BMGBL02 | I-Monoclonal | Impuku | Isampulu yoNyango lwePad | LF, IFA, IB, WB | / | Khuphela |
| I-Blocker Antibody | BMGBL03 | Impuku | Impuku | Isampulu yoNyango lwePad | LF, IFA, IB, WB | / | Khuphela |
| I-Blocker Antibody | BMGBLP1 | Polyclonal | Impuku | Isampulu yoNyango lwePad | LF, IFA, IB, WB | / | Khuphela |
| I-Blocker Antibody | BMGBLP2 | Polyclona | Umvundla | Isampulu yoNyango lwePad | LF, IFA, IB, WB | / | Khuphela |
| I-Blocker Antibody | BMGBLP3 | Polyclonal | Ibhokhwe | Isampulu yoNyango lwePad | LF, IFA, IB, WB | / | Khuphela |
I-blocker yi-agent ye-biological eyongeziweyo kwi-immunoassay ukuze ibophe i-heterophile antibodies, ikhusela ngokufanelekileyo i-anti-analyte-mediated antibody ligation.
I-blocker yi-agent ye-biological eyongeziweyo kwi-immunoassay ukuze ibophe i-heterophile antibodies, ikhusela ngokufanelekileyo i-anti-analyte-mediated antibody ligation.Isetyenziswa kakhulu kwi-enzyme-linked, i-immunofluorescence kunye ne-chemiluminescence.Abathinteli banokuvimba ukuphazamiseka okwenzeka ngexesha lovavanyo, kwaye bahlulwe kwi-block blocker kunye nabathinteli abasebenzayo.
